• Increase font size
  • Default font size
  • Decrease font size

Continuation pattern still playing out

Written by BioMedReports.Com   
Thursday, 02 February 2012 09:30
Technical IndicatorThis information is posted for premium subscribers first.
Read more...
 

Volume and interest rising in this ambitious program

Written by M.E.Garza   
Tuesday, 31 January 2012 08:41
FDA CalendarThis information is being posted for premium subscribers only.
Read more...
 

Some Important Technical Notes

Written by MarketScanners   
Wednesday, 25 January 2012 08:47
FDA CalendarThis market research is being provided to our subscribers first.
Read more...
 

Watch shares of this big board biotech penny

Written by Staff and Wire Reports   
Monday, 23 January 2012 08:17
FDA CalendarThis information is being posted for premium subscribers only
Read more...
 

Medical Device Pick Updates

Written by M.E.Garza   
Monday, 16 January 2012 02:33

FDA CalendarThis article is being posted for our premium subscribers first.

Read more...
 

News Notes

Written by M.E.Garza   
Friday, 13 January 2012 05:51
Biotech tradingThis information is being posted for premium subscribers only.
Read more...
 

Hepatitis C Notes

Written by M.E.Garza   
Sunday, 08 January 2012 08:29
Biotech NotesThis market information is being posted for our premium subscibers first.
Read more...
 

News developments

Written by M.E.Garza   
Thursday, 05 January 2012 08:37
This information is being posted for our premium subscribers only.
Read more...
 

Insider buying continues

Written by Staff and Wire Reports   
Tuesday, 27 December 2011 13:01
insider buysThis information is posted for premium subscribers only. The heavy insider buying has continued at Opko Health (NYSE:OPK) throughout the holidays.
Read more...
 

Plenty of headroom to run

Written by M.E.Garza   
Friday, 16 December 2011 14:37
This report is being posted for subscribers first.
Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 48
about 4 hours ago Medgenics ($MDGN) up 10% on Monday! We first told you about the firm last Friday: http://t.co/aD50CMSH
about 4 hours ago Thinly traded BioLineRx shares move on hepatitis C deal: The shares of thinly traded BioLineRx (NASDAQ:BLRX) soa... http://t.co/ugbuZgNN
about 9 hours ago Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment; Acorda Announces Launch of Generic ... http://t.co/vSt6VrLP
about 13 hours ago $CVM up 17% and technically looks like it may head higher.
about 19 hours ago $ANAC drops after GlaxoSmithKline (GSK) pauses enrollment for its clinical trials of its urinary tract infection drug. http://t.co/yUUSzkUr
about 19 hours ago Catalysts on tap for Corcept: Corcept Therapeutics (NASDAQ:CORT) is a drug discovery company focused on the deve... http://t.co/jd3C1ddH
about 20 hours ago Commented on: "Will Celsion's Upcoming Catalysts Help The Price Break-Out Stick?" http://t.co/dJ0reUFR $BSX $PHG $MDSO $CLSN
about 20 hours ago Monday morning watch -- European Leaders Maintain Pressure on Greece to Complete Terms for Bailout - http://t.co/0wipY6QB via @BloombergNews

navigation

Free Phone Trade Alerts